Moreover, analysis of genome-wide CRISPR screens for cancer genetic vulnerability (depmap.org) demonstrated the selective essentiality of SMARCA4 in NB cell lines, distinguishing it from most other cancers (Fig. 1A, right panel). This evidence concerns the gene SMARCA4 and cancer.